CVSUS · CVS Health Corporation
86.95
USDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
n/a
PE
57.10
EV/EBITDA
9.1
DIV Yield
3.4%
Payout Ratio
191%
MQV Rating
5Very Weak
As at 09/10/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- Near Support
Key Fundamentals
EPS 3 yr Growth
-57.50%
EBITDA Margin
4.20%
Operating Cashflow
$10,639m
Free Cash Flow Return
7.10%
ROIC
1.20%
Interest Coverage
5.50
Quick Ratio
0.60
Performance
52 weeks range
Low 75 - 106.32
Trade Value (12mth)
US$401.00
1 week
-7.06%
1 month
10.06%
YTD
6.36%
1 year
0%
All time high
109.11
Additional Data
Shares Outstanding (Fully Diluted)
1,287m
HALO Sector
Healthcare
Next Company Report Date
N/A
Next Ex Dividend Date
22-Oct-26
Next Dividend Pay Date
02-Nov-26
Reporting Currency
USD
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Very Weak
Earnings
Very Weak
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| J. David Joyner | Individual |
| Parkwood LLC | Private Company |
| Mubadala Investment Co. (Investment Company) | Operating Division |
| C. David Brown | Individual |
| Prem S. Shah | Individual |
